Ernexa Therapeutics Inc. Finance Lease, Liability, Current
Ernexa Therapeutics Inc. (ERNA) had Finance Lease, Liability, Current of $3.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2022-11-14
- 2022-09-30: Finance Lease, Liability, Current $3.00K.
- 2021-12-31: Finance Lease, Liability, Current $0.00.
- 2020-12-31: Finance Lease, Liability, Current $22.00K.
- 2020-09-30: Finance Lease, Liability, Current $23.00K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2022-09-30 | $3.00K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-14 |
| 2020-12-31 | $22.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $23.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $24.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $21.00K 10-Q · filed 2020-05-20 |
| 2019-12-31 | $21.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $22.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $25.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $32.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |